Member Info for VanVan

The Capital Markets Day presentation went on for about 2 hours, but it was brilliant. Compare this to the likes of KEFI & AAU and many others and they just aren’t in the same league.

It filled me with great confidence.

The first mine is up & running as you know and will be cash flow positive in H2. By 2026, it will be making about $100m gross profit with more upside to come. The next mines probably don’t come on stream, till 2029/2030, but the exploration (resource) work in the meantime looks impressive. They value the exploration assets opportunity at circa C$20 billion (Over £10bn)!

Lovely to hear a Co. with confidence to quote numbers.

If these assets starts to relise their asset potential (massive grades, near surface etc.) this will surely get taken out way before full value is realised.

Then there are two service Co’s run as separate entities. Hydro Power and Mining equipment etc. They get their own funding.

They say they have the strongest mining team in Europe. 300 people and a great Mgmt team who all spoke. None of this single guy stuff like Harry Adams (KEFI) & Kerim Sener (AAU). Proper people mgmt and delegation. A "family" type affair with enthusiasm and clear business values/ethics. A vision, objectives and strategies. All fully worked out and understood by everyone. A class act for sure.

And a strong balance sheet with Revolving Credit of $75m in place.

Good support from the Govt. and Pension funds etc.

I loved it. If you get the chance, do have a listen.

Presentation still going on. Very thorough.

Amazingly exciting.

What incredible opportunities.

This is a growth share bar none.

My only concern is that they are trying to take on too much.

This presentation is a must to hear and see.

AMRQ - AMAROQ MINERALS LTD.

7:00: Q1 2026 Operational and Financial Results

Financials: Q1 revenue C$18.9m, gross profit C$9.8m, net profit C$2.4m; gold inventory C$20.3m; capital assets C$275.4m; cash C$8.8m (down from C$21.5m at FY2025); post-period RCF increased to US$70m, improving liquidity and reducing funding cost.

Operations/Production: Nalunaq produced 3,694 oz (sales 2,970 oz) from 12,032 t processed at 19.9 g/t (vs guidance 14–15 g/t) with 61% recoveries under gravity-only circuit; flotation circuit commissioning in Q2 expected to raise recoveries toward ~90–95% and concentrate production in H2 2026.

Capital & Corporate: Completed transition to owner-operated underground fleet; received Final Mine Plan/Closure approval; reiterated intent to upgrade to LSE Main Market and voluntarily delisted from TSXV; working capital reported C$24.3m (no loan payable) improving balance-sheet clarity.

Outlook / Exploration: Reiterated FY2026 production guidance 25–35 koz (H2-weighted); 2026 field programme kicking off June at Ilua (REE) with subsequent campaigns at Minturn (IOCG), Nanoq (maiden MRE target) and Black Angel refurbishment/drilling planning in July–August.

Eldur Olafsson, CEO of Amaroq, commented:

“I am pleased to report a strong first quarter’s operational and financial performance, in line with expectations and guidance for the full year. Mining operations and processing at the Nalunaq gold mine performed well, with gold grades and recoveries very much in line with guidance.

“With the completion of Phase 1 commissioning, we continued to ramp up mining and milling rates through the quarter and successfully navigated the challenging winter month personnel rotations. Current trading has been strong, keeping us on track for the H1 2026 guidance of 7 to 10koz of gold and full year of 25 to 35k oz. I am also excited that we will be kicking off our high impact 2026 exploration campaign in June 2026, starting at the Ilua Rare Earth prospect.

“In addition, today we are hosting a capital markets update in London, showcasing the extensive growth pipeline we are looking to unlock over the next five years, as well as a deeper look into the Nalunaq gold mine and its own resource and production growth potential; highlighting the significant latent value we have within the business ready to be realised. Amaroq has started 2026 in a very strong position and I look forward to updating the market as this year progresses.”

Scancell is up circa 50% since 24th April and following just the "Fast Track" RNS on 28th April.

This is a massive turnaround having been in the doldrums for so long.

Is it "leaky" or is it as a result of closing the "overhang", or is it FOMO momentum?

I hope we get tangible news this week to show there is a foundation to this 50% increase in the Market Capitalisation.

I think next week is going to be really interesting in terms of progress on many fronts. We seem to have fallen under the radar which is no bad thing as the potential gets ever mire cemented in place. Over the next 3 to 4 years the realisation of all the value strings could be quite exceptional. I believe in Eldur to bring about transformational progress and excite the World in the potential of Greenland. Happy to be a long term investor.

Don’t forget to vote on the Resolutions. Kerim & Michael de Villiers up for re-election. Many will be voting against their re-appointment especial Michael de Villiers. Surely we don’t need that cost, now we have a new Chairman in Michael Atkins.

Https://www.marketscreener.com/news/arbitration-clauses-not-a-shield-against-a-winding-up-petition-ce7f5bdbd888f72d

Thanks guys .

Oh, I do have one question of you knowledgeable investors here? Do we know why the big investor Nick CANDY reduced his holding some time ago from 959m shares to I believe 653m shares. Is there a bit of a story behind this Candy investment?

Oh and one more question, Has the Co. said how long it will take them to get from First Gold pour (hopefully before Christmas this year) to Steady State production? I know today they say they will announce formal 2027 Guidance in 2027. Thanks.

I do like the communications here. Previous Gantt chart out to first gold pour is something many try and avoid. Then there is a ring of openness and honesty in the text which I am sure investors appreciate.

But there can be no doubt they are doing very well to keep ahead of schedule and there are lots of value accretive milestones still to come in the near term. And the size of the ultimate potential here can't help but leaving one quite excited for the future.

Tom Winnifrith has just posted a piece on AAU. Positive comments. Paywall so can’t reproduce I’m affraid

Why don’t we hear anything about the NHS partnership? How is that partnership going?

“Partnership with the NHS Cancer Vaccine Launch Pad (CVLP) to fast-track access for NHS patients into the fourth cohort of the Company's Phase 2 clinical SCOPE study.”

Message from Kathryn at Ithaca Energy.

Our results are being held on the 20 May and there will be an update to trading and operations then.

AGM 21st May and Capital Markets Day 2nd June as I understand

Lots of quality news is imminent.

AGM this Thursday and Capital Markets Day on Wed 13th May. So watch the noise increase and investors tweak their ears & hit the BUY button.

We are looking Nalunaq Phase 2 Floatation circuit to complete this quarter and Recovery rates to dramatically improve to circa 90% plus.

We should get an update on the underground mining fleet activity at Nalunaq as well.

Then we should get the Nanoq Feasibility Study this year. Not sure when, but we should get an update and perhaps a likely date. A Feasibility Study for this potential "world class mine"' must be value accretive.

They say the Co. will be profitable this year. I look forward to getting confirmation of that.

Oh, and the Main Market listing could be done by June, or if not that window, should be September 2026.

So lots to anticipate and the Share Price has hardly performed of late given we are so close to a highly profitable operation, so a nice short term upside seems likely to me. And no threat of dilution leading up to steady state production of 75,000 ozs pa from 2027 given the recent uplift in the Credit facility. I feel very positive.

NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS OF AMAROQ LTD.

TO BE HELD ON MAY 07, 2026

Yes that is very encouraging. Phase 111 is what is going to get us noticed I guess. But presumably this relies on funding or partnership pre the Phase 111. So a big milestone mustn't be too far off.

I would have thought time is over due to be listed on NASDAQ, especially if funding is now a key issue.

Presumably the funding need is sizeable and hasn't been quantified as yet.

And I assume a Modi 1 data update is due quite soon.

And Phil L'Huillier is a keynote speaker at UK Biotech Day on 27/28th May.

How long does Phase 3 take? I know results will be available in 2027. Exciting times for sure. Message getting through. Just imagine if we were joint listed on Nasdaq & London

Momentum is building in late-stage melanoma.🎯

ImmunoBody® iSCIB1+ has received FDA Fast Track designation, recognising its potential to address a serious unmet medical need and enabling closer interaction with the FDA as the programme moves into Phase 3.

The designation provides eligibility for expedited regulatory pathways, including Accelerated Approval, Priority Review, and Rolling Review, where criteria are met.

Progression-free survival (PFS) in the target population is reported at 77% at 20 months. This represents a 30+ percentage point improvement over standard of care.

#Oncology #Immunotherapy #Biotech

https://lnkd.in/e5MSWnpr